How is sputum testing performed for pulmonary tuberculosis when no sputum is present?

There are many types of pulmonary diseases, and pulmonary tuberculosis (TB) is one of them. It poses serious harm to patients’ health and is highly contagious. Anyone diagnosed with TB in daily life must remain vigilant, seek timely diagnosis and treatment at a hospital, and implement preventive measures regularly to avoid disease progression.

How is sputum testing performed in pulmonary tuberculosis patients without sputum?

In cases where patients with pulmonary tuberculosis cannot produce sputum, sputum examination may not be feasible; alternative diagnostic methods can be employed instead. Reduced mucus secretion in the respiratory tract—caused by Mycobacterium tuberculosis infection—often leads to symptoms such as dry cough and absence of sputum. In such instances, diagnosis can be further supported by evaluating clinical manifestations, imaging studies (e.g., chest X-ray or CT), the purified protein derivative (PPD) skin test, and the interferon-gamma release assay (IGRA), such as the T-SPOT.TB test. Common clinical features of pulmonary TB include persistent cough, fatigue, night sweats, low-grade fever, and unintentional weight loss. Some patients may experience hemoptysis, while those with tuberculous pleurisy may report varying degrees of chest pain.

The PPD skin test—also known as the tuberculin skin test—is typically read 48–72 hours after intradermal injection. A reaction characterized by induration or erythema measuring ≥20 mm in diameter—or the presence of local vesicles or necrosis—is interpreted as a strongly positive result. Most TB patients exhibit an elevated erythrocyte sedimentation rate (ESR), whereas C-reactive protein (CRP) levels usually remain normal or only mildly elevated.

In daily life, patients should maintain a regular, balanced diet—avoiding spicy, irritating foods and refraining from overeating or staying up late. We hope this information proves helpful.